BML Capital Management »

Athira Pharma shares owned by BML Capital Management

Quarter-by-quarter ownership of Athira Pharma shares owned by BML Capital Management from 13F filings

Historical chart of BML Capital Management investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by BML Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 323k 4.14

More positions owned by BML Capital Management

Aclaris Therapeutics (ACRS)
Atea Pharmaceuticals (AVIR)
Adverum Biotechnologies Com New (ADVM)
Instil Bio Com New (TIL)
Oramed Pharmaceuticals Com New (ORMP)
Pmv Pharmaceuticals (PMVP)
Alumis (ALMS)
Lava Therapeutics Nv SHS (LVTX)
Kezar Life Sciences Com New (KZR)
Connect Biopharma Hldgs SHS
Imagenebio
Athira Pharma
Astrotech Corp (ASTC)
Target Corporation (TGT)
Vistagen Therapeutics Ord (VTGN)

View all positions for BML Capital Management

Top funds holding Athira Pharma

Perceptive Advisors
BML Capital Management
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
Renaissance Technologies
Acadian Asset Management
Pathstone Holdings
BlackRock
Citadel Advisors
Geode Capital Management
Susquehanna International
Two Sigma Advisers
State Street Corporation

View all funds holding Athira Pharma